ghk cu what is it GHK-CU – Research Peptide GHK-cu – MCCM Medical Cosmetics

J Clin Invest 2010;120:1774-85

It's the part of the syringe that gives the user something to hold

They've been called everything from the next big breakthrough to just another hyped ingredient

The REDEFINE clinical trial program has established that: Cagrilintide 2.4 mg + Semaglutide 2.4 mg weekly produces superior weight loss compared to either agent alone The combination achieved 22.7% mean weight reduction at 68 weeks Side effect profiles were manageable with proper dose escalation The amylin + GLP-1 agonist combination demonstrated synergistic effects This validated combination demonstrates that pairing cagrilintide with incretin-based therapies can work effectively